It lasted longer than it originally thought it would, but Genesis Research is finally shutting down its New Zealand operations after running out of cash.
The listed research company indicated in February last year that it did not have the funds to continue for another 12 months, but it kept going for another 14 before this morning’s announcement.
In a statement released to the share market, Genesis said it was still negotiating several transactions, including a company with “several therapeutic development projects” that would be initially funded by a $450,000 placement of shares.
But Genesis chief executive Stephen Hall said there were not enough funds to allow ongoing development of its Solirna technology in New Zealand.
“The Foundation for Research Science and Technology has declined to provide any substantive funding and at this stage the Japanese investor in Solirna is still determining whether it will provide further funding.”
Genesis was founded in 1994 and is targeting therapies for immune disorders and cancer.
It recorded a full year loss of $0.8 million in 2009, after slumping to a full year loss of $7.5 million the previous year, with its cash balance down to $0.3 million by the end of the year.
In March it completed a $193,000 share purchase plan.
It remains a minnow on the new Zealand stock market (NZX: GEN), trading for less than 20c since the start of 2008. Shares are currently worth 6c.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Aussie radio man tipped to replace Weldon as MediaWorks boss
- MARKET CLOSE: NZX50 at new record as global equities rise
- Caltex's AA smartfuel deal to cost Z Energy $5m
- House prices to peak next year on new supply, lower migration: Infometrics
- More attacks at German soft targets highlight the intelligence dilemma
Most listened to
- Trade Me gets fewer snooping requests from govt agencies – but others report mixed results
- NBR's Jenny Ruth outlines the latest development in legal battles in the human resources world
- ‘I can’t understand what their issue is’ – TV3’s Mike McRoberts on Fairfax, NZME’s Rio Olympics boycott
- National's 10% poll jump isn't believable - but the party's support does seem to be holding up
- Nevil Gibson's Editor's Insight names those most affected by the phase-out of ETS subsidies